- Home
- RENB vs FORA Comparison
RENB vs FORA Comparison
Compare RENB & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENB
- FORA
- Stock Information
- Founded
- RENB 2011
- FORA 2014
- Country
- RENB United States
- FORA United States
- Employees
- RENB N/A
- FORA N/A
- Industry
- RENB Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- RENB Health Care
- FORA Technology
- Exchange
- RENB Nasdaq
- FORA Nasdaq
- Market Cap
- RENB 62.0M
- FORA 64.0M
- IPO Year
- RENB N/A
- FORA N/A
- Fundamental
- Price
- RENB $0.34
- FORA $2.15
- Analyst Decision
- RENB
- FORA Strong Buy
- Analyst Count
- RENB 0
- FORA 1
- Target Price
- RENB N/A
- FORA $5.00
- AVG Volume (30 Days)
- RENB 7.5M
- FORA 7.7K
- Earning Date
- RENB 05-15-2025
- FORA 08-13-2025
- Dividend Yield
- RENB N/A
- FORA N/A
- EPS Growth
- RENB N/A
- FORA N/A
- EPS
- RENB N/A
- FORA N/A
- Revenue
- RENB N/A
- FORA $22,332,001.00
- Revenue This Year
- RENB N/A
- FORA $13.31
- Revenue Next Year
- RENB N/A
- FORA $43.65
- P/E Ratio
- RENB N/A
- FORA N/A
- Revenue Growth
- RENB N/A
- FORA 5.22
- 52 Week Low
- RENB $0.27
- FORA $1.85
- 52 Week High
- RENB $2.10
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- RENB 49.44
- FORA 56.15
- Support Level
- RENB $0.32
- FORA $1.95
- Resistance Level
- RENB $0.40
- FORA $2.09
- Average True Range (ATR)
- RENB 0.06
- FORA 0.11
- MACD
- RENB 0.01
- FORA 0.01
- Stochastic Oscillator
- RENB 39.67
- FORA 66.67
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.